5F-EDMB-PINACA

5F-EDMB-PINACA

Synthetic cannabinoid

5F-EDMB-PINACA
[[File:|frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

5F-EDMB-PINACA is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the cannabinoid receptors, specifically the CB1 receptor and CB2 receptor. Synthetic cannabinoids like 5F-EDMB-PINACA are often found in products marketed as "herbal incense" or "potpourri" and are intended to be used as recreational drugs.

Chemical Structure

5F-EDMB-PINACA belongs to the indazole-3-carboxamide family. The chemical structure of 5F-EDMB-PINACA includes a fluorine atom, which is believed to increase its potency and duration of action. The full chemical name is N-(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl-1-(5-fluoropentyl)-1H-indazole-3-carboxamide.

Pharmacology

5F-EDMB-PINACA acts as a full agonist at the CB1 and CB2 receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including mood, memory, and pain sensation. The activation of these receptors by synthetic cannabinoids can lead to effects similar to those of tetrahydrocannabinol (THC), the active component of cannabis.

Legal Status

The legal status of 5F-EDMB-PINACA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. For example, in the United States, it is listed as a Schedule I substance under the Controlled Substances Act.

Health Risks

The use of synthetic cannabinoids like 5F-EDMB-PINACA has been associated with a range of adverse health effects. These can include tachycardia, hypertension, hallucinations, and seizures. In some cases, the use of these substances has been linked to severe outcomes such as acute kidney injury and death.

Related Pages

• Synthetic cannabinoid
• Cannabinoid receptor
• Endocannabinoid system
• Tetrahydrocannabinol
• Controlled Substances Act

This article is a stub related to pharmacology. You can help WikiMD by expanding it!